Difference between revisions of "PCCTech Minutes 2015 02 23"
Jump to navigation
Jump to search
Tsoutherland (talk | contribs) |
Tsoutherland (talk | contribs) |
||
Line 16: | Line 16: | ||
===Intro/Agenda Review=== | ===Intro/Agenda Review=== | ||
* Request to record and make available the DCB discussions for those unable to attend the sessions due to time zone differences | * Request to record and make available the DCB discussions for those unable to attend the sessions due to time zone differences | ||
+ | |||
===RECON on FHIR=== | ===RECON on FHIR=== | ||
* George led discussion, reviewed several sections, made some changes to document | * George led discussion, reviewed several sections, made some changes to document | ||
Line 22: | Line 23: | ||
** will likely need a new transaction that provides more explicit/specific guidance | ** will likely need a new transaction that provides more explicit/specific guidance | ||
− | ===Remote Patient Monitoring=== | + | ===Remote Patient Monitoring (RPM)=== |
* Brian led discussion, reviewed actor/transaction diagrams | * Brian led discussion, reviewed actor/transaction diagrams | ||
* discussion resulted in clarity of actor/transaction definitions, and use of grouping | * discussion resulted in clarity of actor/transaction definitions, and use of grouping | ||
+ | |||
+ | |||
+ | ===Device Clinical Bridge (DCB)=== | ||
+ | * Alex led discussion, reviewed actors/transactions diagrams | ||
+ | * actors and transactions we reworked based on committee feedback | ||
+ | * '''next action:''' Alex to apply changes to DCM document for follow up session | ||
+ | |||
+ | ===Workflow Discussion=== | ||
+ | * Keith led discussion, reviewed selection of BPMN as the standard of choice | ||
+ | * Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL | ||
+ | * '''next action:''' for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN |
Revision as of 09:26, 23 February 2015
Attendees
- Keith Boone
- Alex Lippitt
- Isabelle G
- George Cole
- Mike Bohl
- Tone Southerland
- Thom Kuhn
- Chris Lindop
- Brian Reinhold
- Dave Stumpf
Minutes
Intro/Agenda Review
- Request to record and make available the DCB discussions for those unable to attend the sessions due to time zone differences
RECON on FHIR
- George led discussion, reviewed several sections, made some changes to document
- may need interaction with IHE-HL7 Joint Workgroup, in relation to using the provenance FHIR resource
- discussion around using PCC-1 Share Content
- will likely need a new transaction that provides more explicit/specific guidance
Remote Patient Monitoring (RPM)
- Brian led discussion, reviewed actor/transaction diagrams
- discussion resulted in clarity of actor/transaction definitions, and use of grouping
Device Clinical Bridge (DCB)
- Alex led discussion, reviewed actors/transactions diagrams
- actors and transactions we reworked based on committee feedback
- next action: Alex to apply changes to DCM document for follow up session
Workflow Discussion
- Keith led discussion, reviewed selection of BPMN as the standard of choice
- Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL
- next action: for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN